Many women with ovarian cancer undergo both surgery and chemotherapy and because the majority of women will eventually experience recurrent disease, it is important to recognize how such treatments may disrupt patient quality of life. The authors of this review discuss the quality of life issues, and emphasize the importance of developing further strategies to identify women at risk of serious quality of life disruption so that effective interventions can be designed.
- Charlotte C Sun
- Pedro T Ramirez
- Diane C Bodurka
